Sorafenib (brand nameĀ Nexavar) isĀ an oral multikinase inhibitor used to treat advanced renal cell carcinoma, unresectable hepatocellular carcinoma (liver cancer), and radioactive iodine-refractory differentiated thyroid cancer. It works by inhibiting tumor growth, proliferation, and angiogenesis. Common side effects include hand-foot syndrome, diarrhea, fatigue, alopecia, and high blood pressure













Reviews
There are no reviews yet.